Literature DB >> 27571369

Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions.

Sumiyo Morita1, Hirofumi Noguchi2, Takuro Horii1, Kazuhiko Nakabayashi3, Mika Kimura1, Kohji Okamura4, Atsuhiko Sakai2, Hideyuki Nakashima2, Kenichiro Hata3, Kinichi Nakashima2, Izuho Hatada1.   

Abstract

Despite the importance of DNA methylation in health and disease, technologies to readily manipulate methylation of specific sequences for functional analysis and therapeutic purposes are lacking. Here we adapt the previously described dCas9-SunTag for efficient, targeted demethylation of specific DNA loci. The original SunTag consists of ten copies of the GCN4 peptide separated by 5-amino-acid linkers. To achieve efficient recruitment of an anti-GCN4 scFv fused to the ten-eleven (TET) 1 hydroxylase, which induces demethylation, we changed the linker length to 22 amino acids. The system attains demethylation efficiencies >50% in seven out of nine loci tested. Four of these seven loci showed demethylation of >90%. We demonstrate targeted demethylation of CpGs in regulatory regions and demethylation-dependent 1.7- to 50-fold upregulation of associated genes both in cell culture (embryonic stem cells, cancer cell lines, primary neural precursor cells) and in vivo in mouse fetuses.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27571369     DOI: 10.1038/nbt.3658

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  32 in total

Review 1.  DNA methylation and mammalian epigenetics.

Authors:  W Reik; W Dean
Journal:  Electrophoresis       Date:  2001-08       Impact factor: 3.535

Review 2.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

3.  COBRA: a sensitive and quantitative DNA methylation assay.

Authors:  Z Xiong; P W Laird
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

4.  DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain.

Authors:  T Takizawa; K Nakashima; M Namihira; W Ochiai; A Uemura; M Yanagisawa; N Fujita; M Nakao; T Taga
Journal:  Dev Cell       Date:  2001-12       Impact factor: 12.270

5.  A TALE nuclease architecture for efficient genome editing.

Authors:  Jeffrey C Miller; Siyuan Tan; Guijuan Qiao; Kyle A Barlow; Jianbin Wang; Danny F Xia; Xiangdong Meng; David E Paschon; Elo Leung; Sarah J Hinkley; Gladys P Dulay; Kevin L Hua; Irina Ankoudinova; Gregory J Cost; Fyodor D Urnov; H Steve Zhang; Michael C Holmes; Lei Zhang; Philip D Gregory; Edward J Rebar
Journal:  Nat Biotechnol       Date:  2010-12-22       Impact factor: 54.908

6.  Variations in DNA methylation during mouse cell differentiation in vivo and in vitro.

Authors:  A Razin; C Webb; M Szyf; J Yisraeli; A Rosenthal; T Naveh-Many; N Sciaky-Gallili; H Cedar
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Manipulation of prostate cancer metastasis by locus-specific modification of the CRMP4 promoter region using chimeric TALE DNA methyltransferase and demethylase.

Authors:  Ke Li; Jun Pang; Huaiyan Cheng; Wei-Peng Liu; Jin-Ming Di; Heng-Jun Xiao; Yun Luo; Hao Zhang; Wen-Tao Huang; Ming-Kun Chen; Liao-Yuan Li; Chun-Kui Shao; Ying-Hong Feng; Xin Gao
Journal:  Oncotarget       Date:  2015-04-30

8.  Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer.

Authors:  S Stolzenburg; A S Beltran; T Swift-Scanlan; A G Rivenbark; R Rashwan; P Blancafort
Journal:  Oncogene       Date:  2015-02-16       Impact factor: 9.867

9.  A large-scale in vivo analysis reveals that TALENs are significantly more mutagenic than ZFNs generated using context-dependent assembly.

Authors:  Shijia Chen; Grigorios Oikonomou; Cindy N Chiu; Brett J Niles; Justin Liu; Daniel A Lee; Igor Antoshechkin; David A Prober
Journal:  Nucleic Acids Res       Date:  2013-01-08       Impact factor: 16.971

10.  Optical control of mammalian endogenous transcription and epigenetic states.

Authors:  Silvana Konermann; Mark D Brigham; Alexandro Trevino; Patrick D Hsu; Matthias Heidenreich; Le Cong; Randall J Platt; David A Scott; George M Church; Feng Zhang
Journal:  Nature       Date:  2013-08-23       Impact factor: 49.962

View more
  140 in total

1.  Chemical Control of a CRISPR-Cas9 Acetyltransferase.

Authors:  Jonathan H Shrimp; Carissa Grose; Stephanie R T Widmeyer; Abigail L Thorpe; Ajit Jadhav; Jordan L Meier
Journal:  ACS Chem Biol       Date:  2018-01-17       Impact factor: 5.100

Review 2.  Disentangling chromatin architecture to gain insights into the etiology of brain disorders.

Authors:  Janine M Lamonica; Zhaolan Zhou
Journal:  Curr Opin Genet Dev       Date:  2019-07-16       Impact factor: 5.578

Review 3.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 4.  CRISPR technologies for precise epigenome editing.

Authors:  Muneaki Nakamura; Yuchen Gao; Antonia A Dominguez; Lei S Qi
Journal:  Nat Cell Biol       Date:  2021-01-08       Impact factor: 28.824

5.  Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion.

Authors:  Xiao Wang; Jianan Li; Ying Wang; Bei Yang; Jia Wei; Jing Wu; Ruixuan Wang; Xingxu Huang; Jia Chen; Li Yang
Journal:  Nat Biotechnol       Date:  2018-08-20       Impact factor: 54.908

6.  Neuronal Dnmt1 Deficiency Attenuates Diet-Induced Obesity in Mice.

Authors:  Emily C Bruggeman; John T Garretson; Rui Wu; Hang Shi; Bingzhong Xue
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

Review 7.  Genome and Epigenome Editing in Mechanistic Studies of Human Aging and Aging-Related Disease.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  Gerontology       Date:  2016-12-15       Impact factor: 5.140

Review 8.  Cancer induction and suppression with transcriptional control and epigenome editing technologies.

Authors:  Shota Nakade; Takashi Yamamoto; Tetsushi Sakuma
Journal:  J Hum Genet       Date:  2017-11-14       Impact factor: 3.172

Review 9.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

Review 10.  In vivo epigenome editing and transcriptional modulation using CRISPR technology.

Authors:  Cia-Hin Lau; Yousin Suh
Journal:  Transgenic Res       Date:  2018-10-04       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.